Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 13
2003 8
2004 14
2005 15
2006 11
2007 16
2008 17
2009 11
2010 23
2011 26
2012 20
2013 27
2014 27
2015 25
2016 34
2017 40
2018 33
2019 23
2020 20
2021 17
2022 12
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

387 results

Results by year

Filters applied: . Clear all
Page 1
Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K, Hamada N, Tokunaga S, Ichiki K, Takata S, Ishii H, Kitasato Y, Okamoto M, Kawakami S, Yatera K, Kawasaki M, Fujita M, Yoshida M, Maeyama T, Harada T, Wataya H, Torii R, Komori M, Mizuta Y, Tobino K, Harada E, Yabuuchi H, Nakanishi Y, Okamoto I. Tsubouchi K, et al. Among authors: nakanishi y. BMJ Open Respir Res. 2023 Nov;10(1):e001864. doi: 10.1136/bmjresp-2023-001864. BMJ Open Respir Res. 2023. PMID: 37963676 Free PMC article.
Combination bezafibrate and nivolumab treatment of patients with advanced non-small cell lung cancer.
Tanaka K, Chamoto K, Saeki S, Hatae R, Ikematsu Y, Sakai K, Ando N, Sonomura K, Kojima S, Taketsuna M, Kim YH, Yoshida H, Ozasa H, Sakamori Y, Hirano T, Matsuda F, Hirai T, Nishio K, Sakagami T, Fukushima M, Nakanishi Y, Honjo T, Okamoto I. Tanaka K, et al. Among authors: nakanishi y. Sci Transl Med. 2022 Dec 14;14(675):eabq0021. doi: 10.1126/scitranslmed.abq0021. Epub 2022 Dec 14. Sci Transl Med. 2022. PMID: 36516270
Nab-Paclitaxel for Previously Treated Advanced Non-Small Cell Lung Cancer: Analysis of Safety and Efficacy for Patients With Renal Impairment.
Yoneshima Y, Morita S, Ando M, Nakamura A, Iwasawa S, Yoshioka H, Goto Y, Takeshita M, Harada T, Hirano K, Oguri T, Kondo M, Miura S, Hosomi Y, Kato T, Kubo T, Kishimoto J, Yamamoto N, Nakanishi Y, Okamoto I. Yoneshima Y, et al. Among authors: nakanishi y. Clin Lung Cancer. 2022 Nov;23(7):585-592. doi: 10.1016/j.cllc.2022.08.011. Epub 2022 Aug 22. Clin Lung Cancer. 2022. PMID: 36114096 Clinical Trial.
Emeritus Professor Shu Hashimoto.
Nakanishi Y; APSR members. Nakanishi Y, et al. Respirology. 2022 Sep;27(9):679. doi: 10.1111/resp.14335. Epub 2022 Jul 27. Respirology. 2022. PMID: 35896501 No abstract available.
Antibiotic-dependent effect of probiotics in patients with non-small cell lung cancer treated with PD-1 checkpoint blockade.
Takada K, Buti S, Bersanelli M, Shimokawa M, Takamori S, Matsubara T, Takenaka T, Okamoto T, Hamatake M, Tsuchiya-Kawano Y, Otsubo K, Nakanishi Y, Okamoto I, Pinato DJ, Cortellini A, Yoshizumi T. Takada K, et al. Among authors: nakanishi y. Eur J Cancer. 2022 Sep;172:199-208. doi: 10.1016/j.ejca.2022.06.002. Epub 2022 Jun 30. Eur J Cancer. 2022. PMID: 35780526
387 results